established as an important risk factor for CLAD, with a twofold increased risk of prospectively developing obstructive CLAD observed in two independent cohorts. 3, 4 Given common mechanisms of ACR across organ types, it is important to delineate whether the A-, B-, and E-rejection subtypes reflect pathways common to solid organ transplant rejection or a distinct pathway of rejection unique to lung allografts. 5 The degree of pathway overlap might suggest the extent to which therapies to block rejection might translate.
Gene expression studies in solid organ transplant have demonstrated common signatures of rejection, but the performance of these gene signatures across lung transplant rejection pathologies has not been well described. [6] [7] [8] We hypothesized that LB would be associated with increased expression of gene sets associated with solid organ transplant rejection.
| MATERIAL S AND ME THODS
As illustrated in Figure 1 , we examined ACR pathologies in two cohorts. Detailed methods are described in the supplement. Briefly, we
prospectively collected large airway brushings and performed RNA sequencing on all available cases matched 1:3 to controls. We examined differential pathways and derived a metagene list of differentially expressed transcripts for Cohort 1. In Cohort 2, we performed digital RNA counting on eight paired biopsies from subjects with and without A-, B-, and E-grade rejection. We evaluated the metagene from Cohort 1 in comparison with other published metagenes of solid organ rejection.
| RE SULTS

| Overall characteristics
The subject characteristics for both cohorts ( were present in Cohort 1, but excluded by design from Cohort 2.
It should be noted that more than 80% of subjects in both cohorts were receiving azithromycin prophylaxis. Biopsies from two subjects in the LB group of Cohort 2 were also included in Cohort 1.
| Cohort 1
We assessed which genes were most differentially expressed in LB samples compared to referents. As shown in Figure 2A , expression was increased for 30 genes and decreased for two genes by at least twofold in subjects with LB as compared to controls at a 5% FDR.
The normalized counts for these genes across individual samples are visualized by heat map in Figure 2B . We assessed for overrepresentation of KEGG pathways and Gene Ontology (GO) biological process terms for the 61 genes upregulated at a 10% FDR in LB cases.
Stratifying by infection, there were no differentially expressed genes (FDR > 0.99). Figure 2C shows the pathways upregulated at an FDR of <5%. Notable processes included the GO "Cellular response to interferon-gamma"; KEGG "allograft rejection"; and "antigen processing and presentation" pathways. To visualize the upregulation of genes within these KEGG pathways, we mapped the observed log fold change of these transcripts to the KEGG metabolic pathway map ( Figure 2D ). Again, class I antigen presentation stood out as the most upregulated, with increases in cytotoxic and helper T-cell genes, but no substantive change in B or NK cell genes. Of note, LB was not associated with induction of antibodies to MHC molecules ( Figure S1 ).
| Cohort 2
To understand the relation among the three graded types of ACR, we compared gene expression changes across RNA extracted from paired biopsy tissue samples. We performed principal component analysis ( Figure 3A) , which showed that the most significant determinant in gene expression across the panel was biopsy type, with endobronchial biopsies segregating from transbronchial biopsies.
Clustering according to group was confirmed by PERMANOVA, with a P-value of 0.001. There was some segregation of A-and E-score (but not B-score) cases from controls along the second principal component.
We compared metagenes scores for transcripts previously identified to be indicative of specific cell types between cases and paired controls of pathology subtypes ( Figure 3B ). E-grade rejection was associated with increases in cytotoxic T cells. A-grade rejection showed increased macrophages and also showed increases in T cells,
but not a specific T-cell type. By contrast, the only cell type upregulated in B-grade rejection was neutrophils.
We also evaluated the most differentially expressed transcripts in this cohort ( Figure 3C ). No genes were differentially expressed at an FDR-adjusted P-value threshold of 0.05. At an unadjusted P-value threshold of 0.01, A-grade rejection had the most differentially expressed genes, followed by E-grade rejection. By inspection, many of genes most upregulated in A-and E-grade rejection are genes previously described as upregulated during renal allograft rejection. Figure 4B . We also compared the LB metagene with previously described gene signatures of solid organ transplant rejection. As shown in Figure 4B , for A-grade and E-grade rejection there were statistically significant increases in the Common Rejection Module, the Hallmark Rejection gene signature, and the T cell-mediated renal transplant rejection (TCMR) gene signature. [6] [7] [8] In a sensitivity analysis excluding cases of overlap between the two cohorts, we observed similar increases in these metagenes.
No group had an increase in the antibody-mediated renal transplant rejection (ABMR) gene signature, and there were no statistically significant differences observed for the B-grade pathology cohort.
Finally, we sought to visualize commonalities in differential expression between the two cohorts. For each pathology subtype, we plotted the log fold change in expression as determined in Cohort 2 vs the log fold change from Cohort 1 ( Figure 5 ). We observed a statistically significant correlation between the rank of log fold change in Cohort 1 with Cohort 2 A-and E-grade rejection, but not B-grade rejection.
| D ISCUSS I ON
We compared differential gene expression associated with LB in two cohorts both from airway brushings and stored tissue blocks, and related these changes with those observed in A-and B-grade acute cellular lung transplant rejection. We found agreement between unbiased sequencing of large airway brushes and results from digital counting of RNA probes, a technology that allows robust quantification of transcripts despite the RNA degradation that is observed in FFPE tissue blocks.
Importantly, we also found that A-and E-grade rejection each
were associated with upregulation of multiple gene sets previously F I G U R E 2 Differential gene expression analysis of large airway brushings from subjects with lymphocytic bronchitis (LB) vs controls (Cohort 1). Transcripts upregulated (green) or downregulated (red) in the LB cohort with a false discovery rate (FDR)-adjusted P-value < 0.05 and a log2 fold change >1 are shown by volcano plot (A) and heatmap (B). Pathway analysis was performed on 61 genes upregulated at an FDR-adjusted P-value of <0.1 using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. For these 61 genes, pathways upregulated (at an FDR-adjusted P-value of <0.05) are shown (C) as the percent of upregulated genes of total genes in the pathway (orange) with the unadjusted log P-value (blue). D, Genes in the KEGG antigen presentation and allograft rejection KEGG metabolic pathway maps are shown colored by the observed log2 fold change in gene expression, with upregulated genes in green and downregulated genes in red associated with rejection in other solid organ transplant populations.
While we observed upregulation of class I MHC molecules within Cohort 1, and A-and B-grades within Cohort 2, class I HLA genes are not part of the common rejection module, suggesting multiple pathways are affected. Further, the lack of change in the antibodymediated rejection (ABMR) metagene supports the notion that this common pathology is specific to T cell-mediated rejection. One notable gene upregulated across all groups was JAK3, inhibition of which has been shown to prevent allograft rejection in multiple randomized controlled clinical trials, albeit with increased incidence of infection. 9 The most unifying signal we observed is cellular response to interferon, which is upstream of many of the observed upregulated transcripts from both cohorts, including IDO1, 10 HLA Class I, 11 JAK3, 12 and the CXCL9-11 chemokine family, also known as monokines induced by gamma interferon (MIG). 13 Upregulation of HLA and cytotoxic mediators are also characteristic of autoimmune diabetes and viral myocarditis, which may explain the upregulation of these pathways in Cohort 1. Together, these findings suggest that genes induced by interferon signaling are common to lung transplant pathologies and may be responsible for cytotoxic lymphocyte recruitment to airways.
There are multiple potential explanations for why findings for B-grade pathology differed from A-and E-grade pathologies.
Although we selected the most severe pathology cases available, the pathology severity in the B-grade group was generally F I G U R E 3 Differential gene expression in paired biopsies from subjects with A-, B-, or E-grade rejection as compared with biopsies from the same subject showing no pathology, as determined by digital RNA counting (Cohort 2). A, Principal component analysis shows that samples clustered by endobronchial vs transbronchial biopsy type (P = 0.001 by PERMANOVA). B, Gene signatures specific to leukocyte subtypes were compared between samples using paired t tests, with a dot and whiskers showing the mean and 95% confidence intervals of the difference in metagene score. Increased expression is shown in green. C, Volcano plots demonstrate differential gene expression for each pathology type between cases and paired controls with an unadjusted P-value threshold of 0.01, with increased and decreased expression in green and red, respectively. Labeled genes had an absolute log fold change >1
lower than in the A-and E-grade groups. Further, the control samples for the B-grade pathology group had more BALT than was observed in controls from the other groups, and B-grade pa- 
Correlations between results from Cohorts 1 and 2. Log fold change in differential expression for genes detected by RNAseq from large airway brushes (Cohort 1, x-axis) and detected by digital RNA counting analysis of biopsies with A-, B-, or E-grade rejection (yaxes). Increasing maximum rank for statistical significance across the two assays is shown in blue and the top 10% most significant genes across the two cohorts labeled. Spearman's rank order correlation coefficient (rho) and associated P-values are shown for each rejection type injury and neutrophil-associated gene LCN2, which has also been identified in the BAL of patients with interstitial pulmonary fibrosis. 15 Whether the neutrophil, CCR7+, and/or type-2 inflammation pathways seen in the B-grade group indicate distinct rejection pathology or reflect idiosyncrasies of this cohort will require further studies. On the other hand, the agreement between allograft rejection metagene and E-grade pathology scores may help explain the more statistically significant association with E-grade scores with time to CLAD. Differences between the cohorts make comparison between these techniques challenging, however.
In summary, we identified differentially expressed genes associated with LB. LB had transcriptional changes common to other lung and non-lung allograft rejection pathologies. These findings suggest a common biology of allograft rejection that may present despite heterogeneous histopathologic findings. Thus, gene expressionbased adjuncts could reduce misclassification, potentially leading to improved outcomes.
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